Pharmaceutical Companies: Challenges in Developing New Therapeutic Products
Abstract/Contents
- Abstract
- Ringold talks about how the pharmaceutical industry is built on failure and inefficiency and has a small success rate. This recognition led to Surromed. The low success rate is driving the consolidation of companies, which is giving rise to mega players. Now a blockbuster product has to be a multibillion product. This can only change with a change in the processes it uses. New biotech companies are starving for funding and cash, he notes.
Description
| Type of resource | moving image |
|---|---|
| Extent | 1 digital video file |
| Place | Stanford (Calif.) |
| Date created | February 26, 2003 |
| Language | English |
| Digital origin | born digital |
| Sound content | sound |
| Color content | color |
Creators/Contributors
| Speaker | Ringold, Gordon |
|---|
Subjects
| Subject | Entrepreneurship |
|---|---|
| Subject | Business |
| Genre | Filmed lectures |
Bibliographic information
| Location | https://purl.stanford.edu/qf359sd4132 |
|---|---|
| Location | SC1209 |
| Repository | Stanford University. Libraries. Department of Special Collections and University Archives |
Access conditions
- Use and reproduction
- The materials are open for research use and may be used freely for non-commercial purposes with an attribution. For commercial permission requests, please contact the Stanford University Archives (archivesref@stanford.edu).
- Copyright
- Copyright © 2003 The Board of Trustees of the Leland Stanford Junior University. All rights reserved.
Collection
Stanford Technology Ventures Program, Entrepreneurial Thought Leaders Seminar, videorecordings
View other items in this collection in SearchWorksAlso listed in
Loading usage metrics...